Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10881249rdf:typepubmed:Citationlld:pubmed
pubmed-article:10881249lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10881249lifeskim:mentionsumls-concept:C0876934lld:lifeskim
pubmed-article:10881249lifeskim:mentionsumls-concept:C0019564lld:lifeskim
pubmed-article:10881249lifeskim:mentionsumls-concept:C0039485lld:lifeskim
pubmed-article:10881249lifeskim:mentionsumls-concept:C0205098lld:lifeskim
pubmed-article:10881249lifeskim:mentionsumls-concept:C0014556lld:lifeskim
pubmed-article:10881249lifeskim:mentionsumls-concept:C0016293lld:lifeskim
pubmed-article:10881249lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:10881249lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:10881249pubmed:issue12lld:pubmed
pubmed-article:10881249pubmed:dateCreated2000-7-31lld:pubmed
pubmed-article:10881249pubmed:abstractTextTo detect reduced [11C]flumazenil in patients with temporal lobe epilepsy (TLE) and to relate binding to histopathology.lld:pubmed
pubmed-article:10881249pubmed:languageenglld:pubmed
pubmed-article:10881249pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10881249pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10881249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10881249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10881249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10881249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10881249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10881249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10881249pubmed:statusMEDLINElld:pubmed
pubmed-article:10881249pubmed:monthJunlld:pubmed
pubmed-article:10881249pubmed:issn0028-3878lld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:VapalahtiMMlld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:YlinenAAlld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:PartanenKKlld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:KälviäinenRRlld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:PitkänenAAlld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:RinneJ OJOlld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:NågrenKKlld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:VainioPPlld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:LehikoinenPPlld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:RuottinenH...lld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:OikonenVVlld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:LamusuoSSlld:pubmed
pubmed-article:10881249pubmed:authorpubmed-author:JutilaLLlld:pubmed
pubmed-article:10881249pubmed:issnTypePrintlld:pubmed
pubmed-article:10881249pubmed:day27lld:pubmed
pubmed-article:10881249pubmed:volume54lld:pubmed
pubmed-article:10881249pubmed:ownerNLMlld:pubmed
pubmed-article:10881249pubmed:authorsCompleteYlld:pubmed
pubmed-article:10881249pubmed:pagination2252-60lld:pubmed
pubmed-article:10881249pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:meshHeadingpubmed-meshheading:10881249...lld:pubmed
pubmed-article:10881249pubmed:year2000lld:pubmed
pubmed-article:10881249pubmed:articleTitle[11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology.lld:pubmed
pubmed-article:10881249pubmed:affiliationDepartment of Neurology, University of Turku, Finland.lld:pubmed
pubmed-article:10881249pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10881249pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10881249pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10881249pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:10881249pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10881249lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10881249lld:pubmed